Perimenopausal women over-reported total sleep time by a mean of 35.3 minutes and under-reported wake time compared with Fitbit data.
|Articles|May 11, 2021
- Vol 66 No 5
- Volume 66
- Issue 05
Vol 66 No 05: The May Issue
This month’s edition of Contemporary OB/GYN® features three peer-reviewed articles that offer in-depth guidance and analyses of key topics in ob/gyn.
Advertisement
Diagnosis and Management of Primary Dysmenorrhea
Primary dysmenorrhea is a prevalent, underdiagnosed, but treatable condition.
Diagnosis and Management of Gestational Diabetes
What every ob/gyn needs to know to manage this complication.
Enhanced Recovery After Cesarean Section
A case for adopting some Enhanced Recovery After Surgery (ERAS) principles for cesarean delivery.
Articles in this issue
over 5 years ago
Methotrexate in an Intrauterine Pregnancy – An Interesting Twistover 5 years ago
NASPAG 2021: Hillard’s Highlightsover 5 years ago
Diagnosis and Management of Primary Dysmenorrheaover 5 years ago
Enhanced Recovery After Cesarean Sectionover 5 years ago
Diagnosis and Management of Gestational Diabetesover 5 years ago
Keeping Politicians Out of the Exam Roomover 5 years ago
Behind the Scenesover 5 years ago
Prevalence thresholds of screening testsAdvertisement
Related to this article
Elinzanetant cut moderate-to-severe VMS frequency by ≥50% in 66.9% of US participants compared with 40.5% on placebo.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
A systematic review found transdermal nitroglycerin may modestly reduce hot flashes, but evidence remains limited.
The FDA approved the first generic of Climara Pro, a weekly estradiol/levonorgestrel patch for VMS and osteoporosis prevention in women with a uterus.
The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
The Menopause Society's 2026 meeting in San Diego will tackle estrogen avoidance, cancer survivorship, mood, and sleep.
SWHR, ACOG, and WFRC called for sustained funding after a new women’s health executive order.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
FDA approves first generic estradiol/levonorgestrel weekly patch
3
Executive order directs NIH to create women's health division
4
What to expect at The Menopause Society's 2026 Annual Meeting
5